Drawing for TRANSFORMING MEDICINE THROUGH INNOVATION

USPTO serial 87006120

TRANSFORMING MEDICINE THROUGH INNOVATION

Reviewed by CopyMark Law Group

Reg. 5360667Status 710
Filing date
Status date
Registration date
Dec 19, 2017
Examiner
BLAZICH, JOAN MICHELE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with TRANSFORMING MEDICINE THROUGH INNOVATION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Douglas R. Wolf

Douglas R. Wolf WOLF, GREENFIELD & SACKS, P.C.600 ATLANTIC AVENUEBOSTON, MA 02210-2206UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001kits comprising active chemical ingredients for use in the manufacture of compounded drugs used to treat pain, microbial and fungal infections, gastrointestinal diseases and disorders, cardiovascular diseases and disorders; kits comprising pre-measured and pre-weighed active chemical ingredients for use by pharmacists and physicians in creating compounded drugs and medicines to be used for hormone replacement therapy and for use in the treatment of urological disordersSECTION 8 - CANCELLEDOct 10, 2017
005kits comprising pre-measured and pre-weighed medicines for use in the treatment of pain, microbial and fungal infections, gastrointestinal diseases and disorders, cardiovascular diseases and disorders; kits comprising pre-measured and pre-weighed pharmaceutical medicines for use by pharmacists and physicians in the treatment of hormone replacement therapy and the treatment of urological disordersSECTION 8 - CANCELLEDOct 10, 2017

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 5, 2024C8..CANCELLED SEC. 8 (6-YR)—
Dec 19, 2022REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Apr 29, 2020ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
May 23, 2019CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 23, 2019COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 26, 2019CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 26, 2019COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 19, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 15, 2017SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Nov 14, 2017CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Nov 8, 2017SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Nov 7, 2017AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Oct 24, 2017IUAFUSE AMENDMENT FILED—
Oct 24, 2017EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Mar 15, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 13, 2017EX1GSOU EXTENSION 1 GRANTED—
Mar 13, 2017EXT1SOU EXTENSION 1 FILED—
Mar 13, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 8, 2016NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 13, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 13, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 24, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 10, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 3, 2016DOCKASSIGNED TO EXAMINER—
Apr 23, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 22, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance